Beloranib
An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects
Zafgen · Phase 2 · Completed · Enrollment 160
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.